NCT00028548View on ClinicalTrials.gov

XK469 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

R(+)XK469

Trial Locations (1)

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00028548 - XK469 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter